Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2012 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (153)	2/3/2012 6:21:10 PM
From: IRWIN JAMES FRANKEL	1 Recommendation Read Replies (3) \| Respond to of 513

BULBA, Those guys up over 28% in one month must be cheating. 27.338% is OK. ;-) Seriously, those are stunning returns for one month. Perhaps, we should all quit and call it a year. Congratulations to the top 10 and those with good returns that can't even make the top 10. ij

To: BulbaMan who wrote (153)	2/3/2012 9:42:22 PM
From: D.Lu	Read Replies (1) \| Respond to of 513

Biggest gainers were stellar, while biggest losers were minimally in the red. Signs of a good market?

To: BulbaMan who wrote (153)	2/6/2012 8:29:22 AM
From: Rocky9	Respond to of 513

From the history file - 6 years ago (we are in a volatile industry): 2/3/06 Rank Name Total 1 RKRW 40,404 2 JACK 37,509 3 BULBA 28,026 4 WILDER 26,406 5 QUID 23,839 6 IJ 21,627 7 LJM 20,783 8 MZ 20,444 9 ROBERT 19,346 10 GEORGE 19,328 Message 22131744

To: BulbaMan who wrote (153)	2/10/2012 5:49:26 PM
From: BulbaMan	3 Recommendations Read Replies (3) \| Respond to of 513

2/10/12 Contest Update A breather for biotechs from their 2012 blistering pace was inevitable. So it’s not surprising both the Contest median and NBI dropped for the week. In particular, ARRY’s pricing of its secondary share offering at a substantial discount depressed the Contest median. ARRY is held in 12 Contest portfolios. At Friday’s close, the Contest median was up 20.65% YTD (vs. up 22.78% YTD a week ago). In comparison, the NBI was up 13.86% YTD (vs. up 15.41% YTD a week ago), while the Nasdaq Composite Index was up 11.47% YTD (vs. up 11.54% YTD a week ago). PGO’s portfolio remains in first place with a 38.16% YTD gain. GENE’s portfolio had a good week, moving into second place with a 34.89% YTD gain and helped by a 20% position in PYMX.OB, ROBERT’s portfolio, up 31.68% YTD, jumped into third place. At Friday's close, all 38 Contest portfolios were still in the black with 28 of the 38 beating the NBI. Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks ranked by % Gained and % Lost for the week (foreign stock prices are not converted to US$ in these two tables). Portfolio adjustments: None Have a safe & fun weekend biotechies! (All corrections, especially adjustments for splits, greatly appreciated.) 2/10/12 Rank Name Profit/Loss 1 PGO 38,156 2 GENE 34,892 3 ROBERT 31,682 4 SCARAM 30,576 5 RKRW 30,571 6 RRGE 26,874 7 MOPGCW 26,759 8 BRAD 26,059 9 ARTHUR 25,385 10 DOUGH 24,837 Week's Top 5 Gainers Symbol 2/3 2/10 % change DARA 1.43 1.87 30.77% TTHI 1.54 1.95 26.62% PCYC 19.30 23.23 20.36% PYMX.OB 1.04 1.22 17.31% NVIV.OB 2.09 2.36 12.92% Week's Top 5 Losers Symbol 2/3 2/10 % change NGSX 1.05 0.58 -44.76% AMRS 10.46 6.99 -33.17% MVIR-B.ST71.00 56.75 -20.07% ANAC 7.42 6.19 -16.58% CORT 3.29 2.76 -16.11%